respiratori
tract
infect
rti
among
common
import
problem
clinic
medicin
develop
countri
acut
respiratori
infect
ari
account
major
antibiot
prescript
written
medic
consult
lost
day
work
situat
even
dramat
develop
countri
nearli
mortal
children
age
year
attribut
ari
patient
thought
respiratori
infect
consid
diseas
featur
sequenti
manner
help
focu
differenti
diagnosi
expedit
specif
diagnosi
treatment
start
point
basic
understand
pathophysiolog
respiratori
tract
way
innat
acquir
immun
system
interact
microbi
pathogen
physician
defin
clinic
syndrom
evalu
medic
characterist
affect
patient
context
infect
contract
inform
guid
laboratori
test
imag
acquisit
ancillari
data
need
arriv
final
diagnosi
treatment
plan
chapter
provid
overview
key
concept
relat
rti
emphasi
clinic
microbiolog
aspect
common
infecti
diseas
outcom
rti
complex
interplay
abil
pathogen
infect
colon
damag
tissu
capac
host
mount
effect
immun
respons
primari
function
respiratori
tract
ga
exchang
inspir
air
circul
blood
averag
human
inhal
approxim
breath
air
day
along
contamin
bacteria
viru
fungal
particl
present
aerosol
environ
also
inadvert
microaspir
oropharyng
andor
gastric
content
occur
infrequ
normal
host
extrem
common
critic
ill
mechan
ventil
patient
despit
challeng
lung
bronchi
trachea
larynx
remain
essenti
steril
normal
individu
fortun
respiratori
tract
evolv
withstand
onslaught
potenti
pathogen
varieti
innat
acquir
immun
defenc
exampl
infecti
particl
larger
micron
effici
trap
mucociliari
blanket
line
nare
trachea
bronchi
larg
amount
mucu
produc
goblet
cell
present
ciliat
columnar
epithelium
organ
trap
viscou
layer
direct
ciliari
action
transport
back
throat
swallow
expector
mechan
clearanc
also
facilit
normal
flow
saliva
slough
regener
respiratori
epitheli
cell
oropharynx
competit
resid
normal
flora
invad
pathogen
importantli
respiratori
mucosa
site
product
larg
amount
iga
total
protein
nasal
secret
antibacteri
antivir
activ
immunoglobulin
g
along
complement
present
respiratori
secret
transud
blood
serv
opson
agglutin
neutral
pathogen
organ
similar
role
blood
site
addit
surfac
liquid
airway
contain
wide
varieti
protein
peptid
antimicrobi
properti
includ
lactoferrin
lysozym
cathelicidin
secretori
leukocyt
proteinas
inhibitor
betadefensin
betadefensin
import
famili
cation
antimicrobi
peptid
greatli
enhanc
resist
epitheli
surfac
microbi
colon
interact
neg
charg
membran
gramposit
gramneg
bacteria
fungi
envelop
virus
displac
ca
mg
ion
thu
alter
integr
microbi
membran
addit
defensin
chemokin
attract
macrophag
dendrit
cell
immun
cell
site
infect
thu
serv
dual
role
innat
acquir
immun
system
bacteria
virus
small
reach
termin
bronchiol
alveoli
although
mucociliari
function
level
cellmedi
humor
host
defenc
present
make
deficit
exampl
compon
surfact
phospholipoprotein
complex
secret
type
ii
pneumocyt
sever
import
immun
function
spa
spd
bind
sugar
surfac
pathogen
opson
enhanc
uptak
phagocyt
also
interact
adapt
immun
respons
enhanc
clearanc
pathogen
alveolar
macrophag
neutrophil
free
fatti
acid
variou
ironbind
protein
also
act
within
alveoli
termin
bronchiol
microbiocid
compound
congenit
acquir
damag
mucociliari
defenc
system
increas
risk
infect
develop
primari
ciliari
dyskinesia
pcd
rare
heterogen
group
genet
disord
character
mutat
gene
code
dynein
arm
radial
spoke
protein
associ
cilia
motil
within
respiratori
tract
impair
ciliari
function
reduc
mucou
clearanc
lung
sinus
middl
ear
result
recurr
progress
infect
cystic
fibrosi
common
genet
defect
alter
ciliari
action
discuss
separ
section
pure
mechan
level
alter
level
conscious
drug
intox
anaesthesia
neurolog
impair
even
normal
deep
sleep
result
aspir
oropharyng
gastric
content
lower
respiratori
tract
acquir
damag
mucociliari
apparatu
extrem
common
result
wide
varieti
insult
respiratori
tract
effect
alcohol
studi
extens
damag
host
defenc
occur
multipl
level
addit
suppress
cough
epiglott
reflex
consumpt
alcohol
associ
increas
colon
oropharynx
gramneg
bacilli
also
impair
cellular
immun
respons
infect
decreas
recruit
mobil
neutrophil
lung
block
tnf
respons
endotoxin
increas
product
cytokin
antiinflammatori
properti
tobacco
smoke
air
pollut
detriment
pulmonari
defenc
mechan
interf
mucociliari
action
macrophag
activ
use
divid
rti
involv
upper
lower
tract
clinic
syndrom
involv
upper
tract
includ
otiti
media
mastoid
sinus
pharyng
infect
lower
tract
divid
tracheobronch
bronchiol
pneumonia
condit
exist
acut
chronic
form
acut
diseas
usual
caus
viral
bacteri
infect
chronic
diseas
usual
caus
fungi
slowgrow
bacteria
mycobacteria
bacteria
adapt
persist
biofilm
occasion
less
common
pathogen
parasit
chronic
infect
also
develop
structur
chang
eg
bronchiectasi
nasal
polyp
caviti
occur
result
recurr
especi
sever
acut
infect
surgic
intervent
process
alter
structur
integr
respiratori
tract
otiti
media
refer
infect
inflamm
middl
ear
extrem
common
especi
children
middl
ear
mastoid
caviti
sinus
connect
nasopharynx
pathogenesi
otiti
media
often
relat
obstruct
eustachian
tube
result
fluid
retent
suppur
bacteri
biofilm
format
may
import
pathogenesi
chronic
infect
clinic
manifest
typic
includ
otalgia
ear
pain
decreas
hear
presenc
fever
variabl
mani
patient
otiti
media
experi
viral
upper
respiratori
tract
infect
exacerb
allerg
rhiniti
day
week
onset
symptom
diagnosi
base
clinic
histori
examin
tympan
membran
tympan
membran
normal
transluc
becom
cloudi
opaqu
respons
infect
studi
document
microbiolog
acut
otiti
media
base
needl
aspir
cultur
middl
ear
fluid
streptococcu
pneumonia
haemophilu
influenza
predomin
streptococcu
pyogen
staphylococcu
aureu
moraxella
catarrhali
less
frequent
isol
interest
mani
known
serotyp
pneumonia
rel
small
number
account
major
case
region
differ
predomin
serotyp
note
respiratori
virus
isol
nearli
half
children
acut
otiti
media
frequent
isol
virus
includ
influenza
respiratori
syncyti
viru
rsv
rhinovirus
mastoid
involv
inflamm
infect
mastoid
air
cell
rel
uncommon
clinic
signific
high
close
proxim
brain
larg
cerebr
blood
vessel
almost
patient
acut
mastoid
concurr
otiti
media
fever
sever
pain
behind
ear
worsen
night
persist
otorrhoea
beyond
week
durat
sign
symptom
develop
mastoid
acut
mastoid
extens
ongo
otiti
media
microbiolog
featur
similar
pneumonia
h
influenza
pyogen
commonli
isol
pathogen
import
epidemiolog
observ
increas
frequenc
multidrugresist
pneumonia
isol
approxim
isol
resist
penicillin
resist
macrolid
resist
ceftriaxon
aureu
includ
meticillinresist
strain
becom
increasingli
import
caus
mastoid
sinc
routin
use
pneumococc
vaccin
chronic
mastoid
commonli
occur
background
chronic
suppur
otiti
media
cholesteatoma
format
frequent
isol
organ
includ
pseudomona
aeruginosa
enter
gramneg
bacilli
aureu
varieti
anaerob
bacteria
polymicrobi
infect
common
sinus
also
call
rhinosinus
refer
inflamm
nasal
caviti
paranas
sinus
occur
along
wide
tempor
continuum
rang
acut
symptom
less
week
chronic
symptom
last
week
recurr
acut
sinus
gener
defin
four
episod
per
year
interim
resolut
symptom
us
estim
million
adult
affect
acut
chronic
sinus
econom
impact
billion
annual
vast
major
case
acut
sinus
due
respiratori
virus
eg
rhinoviru
influenza
viru
parainfluenza
viru
clinic
context
common
cold
respiratori
virus
inocul
onto
conjunctiva
nasal
mucosa
suscept
individu
replic
rapidli
symptom
begin
within
day
two
thereaft
fever
myalgia
headach
facial
pain
nasal
discharg
predomin
clinic
featur
ill
almost
alway
selflimit
acut
bacteri
infect
complic
viral
sinus
small
minor
case
despit
statist
larg
percentag
patient
symptom
uncompl
viral
sinus
receiv
prescript
antibiot
thu
contribut
develop
resist
factor
predispos
bacteri
sinus
includ
allergi
obstruct
sinu
drainag
mucociliari
dysfunct
immun
suppress
organ
commonli
associ
acut
bacteri
sinus
outpati
includ
pneumonia
h
influenza
catarrhali
contrast
hospit
patient
develop
acut
bacteri
sinus
commonli
infect
enter
gramneg
bacilli
p
aeruginosa
klebsiella
pneumonia
along
gramposit
organ
usual
aureu
fungal
sinus
import
subgroup
infect
must
distinguish
colon
respiratori
tract
due
inhal
fungal
spore
case
simpl
colon
sinus
littl
clinic
signific
patient
risk
develop
symptomat
diseas
includ
impair
sinu
drainag
chronic
inflammatori
condit
nasal
polyp
structur
abnorm
nasal
septum
sinu
ostia
mani
speci
fungu
report
colon
sinus
aspergillu
spp
among
common
set
poor
sinu
drainag
fungal
hypha
grow
dens
intertwin
collect
refer
fungu
ball
size
ball
increas
eros
wall
sinu
due
mass
effect
surgic
excis
need
remov
fungu
ball
reliev
obstruct
greater
clinic
concern
fungal
sinus
occur
context
immun
suppress
instanc
infect
much
aggress
invas
fungu
sinu
mucosa
underli
bone
vascular
structur
tempo
diseas
gener
depend
level
immun
suppress
profoundli
immunecompromis
patient
experi
acut
diseas
rapid
progress
symptom
sever
day
patient
intact
immun
function
show
chronic
cours
sever
week
month
epidemiolog
invas
fungal
sinus
risen
parallel
increas
number
patient
receiv
bone
marrow
transplant
chemotherapi
solid
organ
transplant
diabet
ketoacidosi
highdos
glucocorticoid
therapi
also
signific
risk
factor
develop
invas
fungal
sinus
especi
due
rhizopu
zygomycet
although
cultur
use
determin
aetiolog
agent
infect
help
guid
antifung
therapi
biopsi
often
necessari
document
whether
invas
infect
present
rather
colon
sinu
caviti
pharyng
typic
manifest
sore
throat
exacerb
swallow
patient
fever
along
constitut
sign
symptom
headach
malais
swollen
cervic
lymph
node
clinic
syndrom
pharyng
one
common
reason
seek
medic
care
account
million
outpati
visit
year
us
noninfecti
caus
includ
season
allergi
exposur
smoke
pollut
poorli
humidifi
air
infecti
caus
includ
wide
varieti
viral
bacteri
pathogen
essenti
respiratori
virus
rhinoviru
coronaviru
influenza
viru
etc
caus
pharyng
well
herp
simplex
viru
viru
human
immunodefici
viru
bacteri
pharyng
due
group
streptococcu
ga
present
sudden
onset
sore
throat
tonsillar
swell
fever
cervic
lymphaden
import
treat
ga
pharyng
order
prevent
suppur
nonsuppur
complic
sinus
retropharyng
abscess
rheumat
fever
acut
glomerulonephr
betahaemolyt
streptococci
eg
group
c
g
typic
associ
develop
rheumat
fever
role
antimicrobi
therapi
less
certain
less
common
bacteria
associ
pharyng
includ
neisseria
gonorrhoea
chlamydophila
pneumonia
arcanobacterium
haemolyticum
mycoplasma
pneumonia
corynebacterium
diphtheria
tracheobronch
usual
selflimit
inflamm
trachea
bronchi
due
infect
patient
bronchiti
present
cough
sputum
product
usual
lack
fever
tachycardia
tachypnoea
acut
bronchiti
differenti
chronic
bronchiti
base
durat
symptom
exampl
chronic
bronchiti
patient
chronic
obstruct
pulmonari
diseas
character
cough
last
least
month
two
success
year
viral
infect
common
caus
acut
bronchiti
influenza
b
parainfluenza
rsv
rhinoviru
human
metapneumoviru
isol
frequent
especi
import
recogn
influenza
infect
rel
higher
morbid
specif
antivir
therapi
avail
controversi
whether
bacteri
organ
commonli
associ
pneumonia
adult
eg
pneumonia
h
influenza
catarrhali
etc
caus
isol
acut
bacteri
bronchiti
howev
three
organ
pneumonia
c
pneumonia
bordetella
pertussi
agent
whoop
cough
shown
caus
acut
bacteri
bronchiti
treatment
pertussi
indic
reduc
durat
symptom
transmiss
infect
bronchiol
inflammatori
condit
affect
primarili
bronchiol
small
airway
less
mm
diamet
complex
disord
differ
significantli
paediatr
adult
popul
children
affect
younger
year
old
common
cold
symptom
sever
day
diseas
progress
involv
lower
airway
result
persist
cough
wheez
rapid
breath
infant
young
children
increas
risk
develop
labour
breath
result
cyanosi
apnoeic
episod
requir
hospit
diseas
also
especi
sever
children
underli
pulmonari
cardiac
diseas
caus
bronchiol
usual
viral
rsv
common
aetiolog
rsv
infect
occur
epidem
peak
januari
februari
northern
hemispher
june
juli
southern
hemispher
although
infecti
bronchiol
occur
adult
rare
compar
seen
children
rsv
adenoviru
pneumonia
report
infecti
aetiolog
often
aris
inhal
injuri
toxic
fume
drug
ingest
idiopath
identifi
precipit
caus
pneumonia
character
inflamm
lung
parenchyma
infiltr
alveolar
space
pulmonari
interstitium
fluid
inflammatori
cell
fibrin
debri
histolog
pattern
inflamm
vari
depend
pathogen
involv
neutrophil
lymphocyt
granulomat
combin
three
fig
list
infecti
agent
associ
pneumonia
extens
includ
wide
varieti
virus
bacteria
fungi
parasit
pneumonia
associ
signific
morbid
mortal
age
group
develop
countri
pneumonia
major
caus
mortal
young
children
physician
defin
specif
pneumonia
syndrom
base
factor
clinic
present
epidemiolog
consider
laboratori
result
individu
patient
goal
narrow
list
organ
might
caus
diseas
target
therapi
provid
time
costeffect
manner
communityacquir
pneumonia
cap
defin
pneumonia
develop
outpati
set
within
hour
admiss
hospit
ill
often
herald
sudden
onset
fever
chill
associ
chest
pain
cough
product
purul
sputum
constitut
symptom
fatigu
anorexia
sweat
nausea
common
physic
examin
patient
often
febril
tachypno
tachycard
although
vari
greatli
depend
age
patient
factor
clinic
evid
pulmonari
consolid
confirm
radiograph
imag
fig
white
blood
cell
count
often
elev
rang
leukopenia
present
poor
prognost
sign
haematocrit
haemoglobin
valu
usual
normal
microscop
examin
sputum
gram
stain
reveal
numer
neutrophil
bacteria
singl
bacteri
morpholog
predomin
help
establish
diagnosi
howev
caution
appli
colon
organ
present
larg
number
contamin
oral
flora
confus
interpret
blood
cultur
posit
minor
case
cap
use
establish
aetiolog
agent
import
recogn
even
extens
evalu
microbiolog
diagnosi
made
case
spectrum
pathogen
associ
cap
quit
vari
depend
least
part
whether
patient
otherwis
healthi
comorbid
nonetheless
studi
show
pneumococcu
account
major
case
cap
comorbid
put
patient
risk
sever
pneumococc
diseas
includ
surgic
function
asplenia
immunoglobulin
defici
h
influenza
caus
pneumonia
featur
similar
pneumococcu
less
frequent
account
case
overal
aureu
tradit
associ
cap
small
percentag
case
howev
increas
signific
elderli
coinfect
patient
influenza
viru
last
decad
increas
concern
global
spread
camrsa
strain
although
often
associ
skin
soft
tissu
infect
camrsa
pneumonia
occur
quit
sever
associ
high
mortal
rate
pneumonia
due
enter
gramneg
bacilli
klebsiella
pseudomona
enterobact
occur
elderli
debilit
patient
alcohol
chronic
obstruct
pulmonari
diseas
cystic
fibrosi
especi
consid
patient
recent
hospit
atyp
pneumonia
somewhat
confus
term
gener
refer
cap
due
less
common
agent
legionella
chlamydophila
mycoplasma
incid
legionella
infect
seem
vari
greatli
base
geograph
locat
mycoplasma
tend
infect
younger
individu
occur
epidem
enclos
popul
colleg
militari
base
viral
infect
import
caus
cap
especi
young
elderli
difficult
distinguish
clinic
bacteri
pneumonia
recent
studi
aid
avail
sensit
molecular
detect
system
show
around
hospit
patient
pneumonia
viral
infect
influenza
viru
rsv
human
metapneumoviru
common
follow
parainfluenza
virus
enterovirus
coronaviru
recent
year
novel
strain
coronavirus
avian
influenza
virus
recogn
great
concern
associ
high
morbid
mortal
hospitalacquir
pneumonia
hap
defin
pneumonia
occur
day
admiss
hospit
unrel
ill
howev
recent
chang
healthcar
deliveri
result
substanti
amount
sophist
intens
care
eg
chemotherapi
dialysi
wound
care
deliv
outpati
set
practic
blur
distinct
cap
hap
appropri
design
might
healthcareassoci
pneumonia
hcap
sever
factor
contribut
substanti
differ
microbiolog
cap
hcap
first
antimicrobi
pressur
hospit
nurs
home
driven
sharp
rise
incid
multidrugresist
bacteria
also
hospit
patient
intens
care
unit
rapidli
colon
oropharynx
enter
gramneg
bacilli
widespread
use
antacid
histamin
type
blocker
promot
stomach
colon
similar
organ
patientrel
risk
hcap
includ
advanc
age
multisystem
organ
failur
malnutrit
numer
neurolog
factor
contribut
overt
silent
aspir
infect
control
practic
hand
hygien
proper
decontamin
medic
equip
also
substanti
affect
risk
infect
singl
biggest
risk
acquir
hcap
use
mechan
ventil
studi
document
increas
risk
infect
compar
unventil
patient
strategi
reduc
incid
ventilatorassoci
pneumonia
current
topic
intens
research
interest
given
differ
surpris
half
case
hcap
due
enter
gramneg
bacilli
pseudomona
especi
common
aureu
includ
mrsa
polymicrobi
infect
due
aspir
mix
aerob
anaerob
flora
also
frequent
report
final
viral
pneumonia
due
nosocomi
acquisit
respiratori
virus
frequent
occurr
nurs
home
hospit
immun
statu
patient
crucial
piec
clinic
epidemiolog
inform
evalu
rti
patient
asplenia
congenit
acquir
defici
antibodi
andor
complement
predispos
infect
encapsul
bacteria
pneumonia
neisseria
meningitidi
h
influenza
individu
impair
inflammatori
respons
chronic
steroid
use
defici
cellmedi
immun
advanc
hiv
chemotherapi
organ
transplant
particularli
challeng
predispos
infect
essenti
agent
cap
hcap
along
reactiv
latent
infect
cytomegaloviru
cmv
wide
varieti
medic
condit
predispos
patient
respiratori
infect
classic
exampl
cystic
fibrosi
genet
defect
cystic
fibrosi
transmembran
conduct
regul
cftr
gene
possibl
mutat
identifi
diseas
occur
approxim
live
birth
recess
inherit
result
defect
chlorid
ion
transport
across
epitheli
cell
surfac
lower
respiratori
tract
interfer
mucociliari
clearanc
inhal
pathogen
lead
earli
recruit
neutrophil
inflammatori
defenc
mediat
addit
high
salt
content
surfac
liquid
airway
decreas
activ
betadefensin
lysosom
innat
immun
mechan
end
result
chronic
colon
recurr
infect
p
aeruginosa
aureu
h
influenza
burkholderia
cepacia
group
bacteria
although
surviv
rate
cystic
fibrosi
improv
dramat
past
sever
decad
effect
treatment
avail
current
revers
underli
genet
defect
result
infect
wellknown
associ
underli
disord
increas
risk
pneumonia
includ
chronic
obstruct
pulmonari
diseas
heart
failur
diabet
mellitu
alcohol
patient
appear
condit
time
period
ie
epidem
viru
usual
caus
common
sourc
exposur
bacteri
pathogen
also
possibl
exampl
latter
includ
environment
exposur
legionella
epidem
pneumonia
pertussi
occur
school
close
popul
season
major
factor
respiratori
viral
ill
although
first
patient
viral
epidem
often
treat
bacteri
diseas
inform
clinic
laboratori
allow
less
aggress
appropri
treatment
subsequ
case
geograph
locat
travel
histori
live
condit
import
consider
develop
differenti
diagnosi
exampl
endem
thermal
dimorph
fungi
histoplasma
capsulatum
blastomyc
dermatitidi
coccidioid
immitisposadasii
paracoccidiod
braziliensi
penicillium
marneffi
frequent
caus
cap
defin
geograph
area
howev
without
knowledg
potenti
exposur
agent
diagnosi
often
delay
respons
empir
antibacteri
therapi
extrapulmonari
symptom
becom
appar
similarli
recent
travel
immigr
develop
countri
could
increas
possibl
tuberculosi
patient
otherwis
might
consid
low
risk
final
vocat
recreat
exposur
wild
domest
anim
result
exposur
uncommon
infect
anthrax
brucellosi
q
fever
psittacosi
approach
laboratori
test
highli
depend
sever
ill
clinic
syndrom
evalu
avail
specimen
analysi
rel
mild
infect
otherwis
healthi
individu
often
diagnos
clinic
treatment
empir
contrast
sever
ill
laboratori
confirm
aetiolog
agent
may
valuabl
signific
likelihood
pathogen
present
cover
empir
therapi
result
allow
narrow
antimicrobi
coverag
complet
blood
count
may
give
indic
chronic
diseas
presenc
underli
haematolog
disord
leukopenia
absenc
leukocytosi
may
indic
viral
granulomat
diseas
appropri
clinic
set
sign
sever
sepsi
lymphocytosi
particularli
atyp
lymphocytosi
suggest
viral
caus
thrombocytopaenia
may
indic
sepsi
dissemin
intravascular
coagul
underli
bone
marrow
diseas
hyperglobulinaemia
result
either
chronic
inflammatori
diseas
hiv
chronic
infect
connect
tissu
diseas
plasma
cell
lymphocyt
disord
associ
antibodi
defici
dysfunct
abnorm
liver
renal
function
impli
multisystem
diseas
prompt
search
dissemin
infect
fungal
bacteri
pathogen
present
low
concentr
eg
mycobacterium
tuberculosi
multipl
smear
cultur
may
request
singl
specimen
occur
import
clinician
work
laboratori
priorit
test
diagnost
yield
optim
similarli
unusu
infect
eg
anthrax
plagu
hantaviru
consider
consult
laboratori
allow
appropri
method
detect
use
commun
outbreak
rti
agent
fulli
identifi
least
first
patient
identifi
epidem
result
provid
public
health
offici
serolog
studi
detect
organismspecif
antibodi
may
complement
cultur
result
exampl
serum
antibodi
test
legionella
speci
coxiella
burnetii
c
pneumonia
pneumonia
wide
use
clinic
diagnosi
gener
posit
igm
fourfold
rise
igg
titr
consid
diagnost
refer
laboratori
provid
serolog
test
wide
varieti
pathogen
associ
rti
howev
diagnost
criteria
less
certain
sensit
specif
assay
variabl
detect
antigen
blood
urin
proven
use
number
respiratori
tract
pathogen
enzym
immunoassay
avail
detect
solubl
antigen
l
pneumophila
serogroup
polysaccharid
cell
wall
pneumolysin
antigen
found
serogroup
pneumonia
although
limit
assay
wide
use
hospit
patient
similarli
blood
urin
antigen
test
avail
pulmonari
dissemin
infect
h
capsulatum
b
dermatitidi
neg
result
rule
infect
pathogen
posit
result
high
posit
predict
valu
signific
crossreact
two
fungi
limit
util
test
provid
specif
diagnosi
increas
use
molecular
method
provid
rapid
specif
diagnosi
rti
increas
sensit
specif
test
greatli
enhanc
diagnosi
respiratori
viral
infect
numer
organismspecif
assay
avail
pathogen
current
cost
test
prohibit
effect
use
shotgun
approach
consult
clinic
laboratori
recommend
difficult
case
encount
test
perform
effici
costeffect
manner
